Marloes Verstappen

504 citations

19 papers · 315 indexed · 1 hit paper · h-index 9

Co-authors: Annette H M van der Helm–van Mil Pascal H P de Jong X. Matthijssen Elise van Mulligen Ellis Niemantsverdriet Fenne Wouters T. Huizinga Aleid C. Boer
Topics: Rheumatoid Arthritis Research and Therapies (18 papers)Systemic Lupus Erythematosus Research (12 papers)Autoimmune and Inflammatory Disorders Research (6 papers)
Cited by: Rheumatology Hematology Genetics
Journals: The Lancet Annals of the Rheumatic Diseases Lara D. Veeken
Partner nations: Netherlands United States Russia

In The Last Decade

Marloes Verstappen

19 papers receiving 313 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

2022 96 citations Marloes Verstappen, Yousra J. Dakkak et al. The Lancet profile →

Peers

Countries citing papers authored by Marloes Verstappen

Since Specialization

Citations

This map shows the geographic impact of Marloes Verstappen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marloes Verstappen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marloes Verstappen more than expected).

Fields of papers citing papers by Marloes Verstappen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marloes Verstappen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marloes Verstappen. The network helps show where Marloes Verstappen may publish in the future.

Co-authorship network of co-authors of Marloes Verstappen

This figure shows the co-authorship network connecting the top 25 collaborators of Marloes Verstappen. A scholar is included among the top collaborators of Marloes Verstappen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marloes Verstappen. Marloes Verstappen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis 2024 ·The Lancet Rheumatology ·(unknown),Pascal H P de Jong,Marloes Verstappen,Annette H M van der Helm–van Mil,Elise van Mulligen	1
2	Patients with rheumatoid arthritis presenting with mono- or oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up 2023 ·Lara D. Veeken ·(unknown),Marloes Verstappen,(unknown),Pascal H P de Jong,Annette H M van der Helm–van Mil	2
3	Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA 2023 ·RMD Open ·(unknown),(unknown),(unknown),Marloes Verstappen,Elise van Mulligen,Annette H M van der Helm–van Mil	4
4	Disentangling heterogeneity in contemporary undifferentiated arthritis – A large cohort study using latent class analysis 2023 ·Seminars in Arthritis and Rheumatism ·(unknown),Marloes Verstappen,(unknown),Annette H M van der Helm–van Mil,H.W. van Steenbergen	2
5	An ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis? 2022 ·Lara D. Veeken ·(unknown),(unknown),Marion C Kortekaas,Marloes Verstappen,Sarah Ohrndorf,Elise van Mulligen,Ronald van Vollenhoven,Dirkjan van Schaardenburg,Pascal H P de Jong,Annette H M van der Helm–van Mil	8
6	Hand and foot MRI in contemporary undifferentiated arthritis: in which patients is MRI valuable to detect rheumatoid arthritis early? A large prospective study 2022 ·Lara D. Veeken ·(unknown),Marloes Verstappen,(unknown),Elise van Mulligen,M. Reijnierse,Annette H M van der Helm–van Mil	11
7	Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution 2022 ·Arthritis Research & Therapy ·Marloes Verstappen,H.W. van Steenbergen,Pascal H P de Jong,Annette H M van der Helm–van Mil	12
8	Towards a simplified fluid-sensitive MRI protocol in small joints of the hand in early arthritis patients: reliability between modified Dixon and regular Gadolinium enhanced TSE fat saturated MRI-sequences 2022 ·Skeletal Radiology ·(unknown),Ellis Niemantsverdriet,Marloes Verstappen,Fenne Wouters,J. L. Bloem,M. Reijnierse,Annette H M van der Helm–van Mil	11
9	Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trialbreakdown → 2022 ·The Lancet ·(unknown),Marloes Verstappen,(unknown),Yousra J. Dakkak,L.E. Burgers,Aleid C. Boer,(unknown),(unknown),Karen Visser,Marc R. Kok,Esmeralda T. H. Molenaar,Pascal H P de Jong,Stefan Böhringer,T. Huizinga,Cornelia F Allaart,Ellis Niemantsverdriet,Annette H M van der Helm–van Mil	96
10	Sustained DMARD-free remission in rheumatoid arthritis – about concepts and moving towards practice 2022 ·Joint Bone Spine ·Marloes Verstappen,Annette H M van der Helm–van Mil	8
11	ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation 2022 ·Lara D. Veeken ·Marloes Verstappen,X. Matthijssen,Seán Connolly,Michael A. Maldonado,T. Huizinga,Annette H M van der Helm–van Mil	8
12	Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis 2022 ·Lara D. Veeken ·(unknown),(unknown),Paul-Henry Cournède,Bruno Fautrel,Françis Guillemin,(unknown),(unknown),Marloes Verstappen,Annette H M van der Helm–van Mil,Xavier Mariette,Samuel Bitoun	18
13	Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis 2021 ·Annals of the Rheumatic Diseases ·Fenne Wouters,(unknown),Laurette van Boheemen,Marloes Verstappen,Kulveer Mankia,X. Matthijssen,Annemarie L Dorjée,Paul Emery,Rachel Knevel,Dirkjan van Schaardenburg,René E. M. Toes,Annette H M van der Helm–van Mil	63
14	POS0379 DETERMINING IN WHICH PRECLINICAL STAGE HLA-SHARED EPITOPE ALLELES AND SMOKING EXERT THEIR EFFECT IN THE DEVELOPMENT OF RHEUMATOID ARTHRITIS 2021 ·Annals of the Rheumatic Diseases ·Fenne Wouters,(unknown),Laurette van Boheemen,Marloes Verstappen,X. Matthijssen,Ellis Niemantsverdriet,Rachel Knevel,D. van Schaardenburg,René E. M. Toes,(unknown)	2
15	POS0257 TOWARDS A SIMPLIFIED FLUID-SENSITIVE MRI-PROTOCOL IN SMALL JOINTS OF THE HAND IN EARLY ARTHRITIS PATIENTS: RELIABILITY BETWEEN MDIXON AND REGULAR FSE FAT SATURATION MRI-SEQUENCES 2021 ·Annals of the Rheumatic Diseases ·Ellis Niemantsverdriet,Marloes Verstappen,Fenne Wouters,M. Reijnierse,(unknown),(unknown)	2
16	Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia 2021 ·Scandinavian Journal of Rheumatology ·(unknown),Marloes Verstappen,Fenne Wouters,(unknown),(unknown),(unknown),(unknown),M. Reijnierse,Annette H M van der Helm–van Mil	4
17	Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies—results from a 25 year longitudinal inception cohort 2021 ·Lara D. Veeken ·Marloes Verstappen,X. Matthijssen,Annette H M van der Helm–van Mil	13
18	DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability 2020 ·RMD Open ·Marloes Verstappen,Elise van Mulligen,Pascal H P de Jong,Annette H M van der Helm–van Mil	35
19	Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis 2020 ·Arthritis Research & Therapy ·Marloes Verstappen,Ellis Niemantsverdriet,X. Matthijssen,Saskia le Cessie,Annette H M van der Helm–van Mil	15

About Marloes Verstappen

Marloes Verstappen is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 315 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). The work is most often cited by research in Rheumatology (271 citations), Hematology (80 citations) and Genetics (39 citations). Marloes Verstappen has collaborated with scholars based in Netherlands, United States and Russia. Frequent co-authors include Annette H M van der Helm–van Mil, Pascal H P de Jong, X. Matthijssen, Elise van Mulligen, Ellis Niemantsverdriet, Fenne Wouters, T. Huizinga, Aleid C. Boer, Esmeralda T. H. Molenaar and Dirkjan van Schaardenburg. Their work appears in journals such as The Lancet, Annals of the Rheumatic Diseases and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact